cefuroxime has been researched along with Hyperplasia, Reactive Lymphoid in 1 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saeed, SA | 1 |
| Bazza, M | 1 |
| Zaman, M | 1 |
| Ryatt, KS | 1 |
1 other study available for cefuroxime and Hyperplasia, Reactive Lymphoid
| Article | Year |
|---|---|
Cefuroxime induced lymphomatoid hypersensitivity reaction.
Topics: Aged; Aged, 80 and over; Cefuroxime; Cephalosporins; Diagnosis, Differential; Drug Eruptions; Female | 2000 |